SCHEMBL30169948

SCHEMBL30169948

NC(CCCCB(O)O)(C(=O)O)C1CCN(Cc2ccc(F)c3ccccc23)CC1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 20/20 0.70
ARG2 P78540 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895022 1.00 ARG1 (0.70) ARG1ARG2
SCHEMBL20683410 0.89 ARG1 (0.54) ARG1ARG2
SCHEMBL30169814 0.87 ARG1 (0.73) ARG1ARG2
SCHEMBL895625 0.87 ARG1 (0.73) ARG1ARG2
Hydrochloric Acid SCHEMBL894489 0.86 ARG1 (0.71) ARG1ARG2
SCHEMBL10265666 0.83 ARG1 (0.70) ARG1ARG2
SCHEMBL895258 0.83 ARG1 (1.00) ARG1ARG2
SCHEMBL895255 0.83 ARG1 (1.00) ARG1ARG2
SCHEMBL12292595 0.83 ARG1 (1.00) ARG1ARG2
SCHEMBL895081 0.83 ARG1 (0.73) ARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283332-A1 USES OF ARGINASE INHIBITORS FOR MANAGING KIDNEY DISEASE AND CARDIOVASCULAR CONDITIONS EMORY UNIVERSITY (US) 2023-01-12 WO disclosed